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Introduction
Providing outpatient pulmonary rehabilitation (PR)
following hospitalization for an acute exacerbation
of chronic obstructive pulmonary disease (AECOPD)
has been found to improve exercise capacity, quality
of life and a reduction in unplanned hospital admis-
sions and mortality.1 These positive effects, although
studied in the short term, have led to national and
international guidelines supporting the provision of
post-exacerbation PR (PEPR).2,3 However, uptake is
poor with less than 10% of hospital discharges for
AECOPD completing PEPR.4 We therefore consid-
ered whether it would be effective to delay PR for
patients who have recently been hospitalized for
their AECOPD.
Methods
We conducted a randomized controlled trial (RCT) at
Glenfield Hospital, University Hospitals of Leicester,
United Kingdom over a period of approximately
2 years. Ethical approval was sought and granted
(08/H0406.133). Patients were referred to PR follow-
ing their admission for an exacerbation of COPD and
attended an outpatient assessment and were offered
the study. Inclusion criteria were confirmed diagnosis
of COPD prior to current admission and an increase in
self-reported breathlessness on exertion. Exclusion
criteria were inability to provide informed consent;
acute cardiac event; and the presence of musculoske-
letal, neurological and psychiatric co-morbidities that
would prevent the delivery of PR. Written consent
was gained and patients were randomized by the
sealed envelope technique to either PEPR which
occurred within 4 weeks of hospital discharge or
delayed PEPR (D-PEPR) which commenced 7 weeks
after a control period of no intervention. The PR inter-
vention was identical for both groups. Outcome mea-
sures included the incremental shuttle walking test
(ISWT) and the endurance shuttle walk test (ESWT).
These were repeated at discharge. Health-related
quality of life measures were gathered, but on analy-
sis, there were insufficient complete data sets to
enable accurate analysis so this has not been reported.
PR was delivered twice weekly for 6 weeks, with each
session being 2 hours. It consisted of individualized
aerobic and resistance exercises and education which
covered topics including chest clearance and energy
conservation.
Results
Fifty-seven patients were referred to PR by a variety
of healthcare professionals following an AECOPD
that required a hospitalization. It was initially
intended to recruit n ¼ 120 to this study. However,
recruitment was problematic throughout the study
with only 57 patients referred and of those 36 patients
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were consented and assessed. Figure 1 shows the flow
of eligibility, randomization and follow-up in the
study. As a result of the original sample number not
being met in the allocated time and lower than antici-
pated uptake and retention issues, the trial was termi-
nated prematurely and was deemed a failed trial.
Randomization was not equal across both arms with
n ¼ 24 in the early PR group and n ¼ 12 in the
D-PEPR group. Baseline characteristics are outlined
in Table 1. Both groups were well matched for age,
lung function and exercise capacity (p > 0.05). Previ-
ous admissions and hospitalization data were not
collected.
However, consistent with the literature, we did
document some important improvements in the PEPR
group detailed in Table 2 which shows the mean
57 patients invited to participate
Excluded (n=21)
• Not meeting inclusion 
criteria (n=6)
• Declined participation (n=8)
• Other reasons (n=7)
Consented and randomized (n=36)
PEPR (n=24)
• Received allocated 
intervention (n=22)
• Did not start (n=1) 
Withdrew prior to starting 
(n=1)
D-PEPR (n=12)
• Received allocated intervention 
(n=6)
• Did not receive allocated 
intervention (n=6)
(Dropped out n=4, AECOPD=2)
Withdrawals (n=8)
Dropped out n=6
AECOPD n=2
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Figure 1. Consolidation standards of reporting trials flow diagram of participation.
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Table 1. Baseline characteristics for all patients across both groups.
PEPR (n ¼ 24; mean (SD)) D-PEPR (n ¼ 12; mean (SD))
Age (years) 64.32 (7.37) 65.8 (7.24)
FEV1 (l) 1.10 (0.44) 1.34 (0.54)
FEV1 (% pred) 51.04 (20.46) 52.33 (17.53)
FEV1/FVC ratio 0.46.52 (12.99) 45.45 (9.48)
ISWT (m) 250.80 (170.41) 173.33 (128.44)
ESWT (s) 239.17 (154.64) 186.91 (143.86)
PEPR: post-exacerbation pulmonary rehabilitation; D-PEPR: delayed post-exacerbation pulmonary rehabilitation; FEV1: forced expira-
tory volume in one second; FVC- forced vital capacity; ISWT: incremental shuttle walking test; ESWT: endurance shuttle walk test.
Table 2. Mean changes with 95% CI for patients who completed pulmonary rehabilitation in both groups.
Early PR (n ¼ 14)
D-PEPR at 7 weeks after the control period
of no intervention (n ¼ 6)
Post D-PEPR (n ¼ 3) following
completion of D-PEPR
ISWT (m) 28.67 (5.85–51.49)* 13.33 (52.97 to 26.31) 40.00 (139.37 to 59.37)
p ¼ 0.427
ESWT (s) 250.10 (92.16–407.98)* 23.20 (259.87 to 213.47) 283.33 (736.23 to 1302.90)
CI: confidence interval; PR: pulmonary rehabilitation; D-PEPR: delayed post-exacerbation pulmonary rehabilitation; ISWT: incremental
shuttle walking test; ESWT: endurance shuttle walk test
*p < 0.05.
Week 0 Recruitment following AECOPD
Week 2 Consent and Randomisation
Baseline outcome measures
Week 4 Early Pulmonary Rehab (PR)
commenced
Week 11 Discharge
Outcome measures 
completed
D-PEPR commenced
Outcome measures completed
Week 18 Discharge
Outcome measures completed
Figure 2. Patient flow through study at time points of outcome measures.
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changes after early PR in the first column, repeated
outcome measures after a control period for the
D-PEPR group and the post D-PEPR mean changes.
Figure 2 outlines the flow of patients through the
study and the time points of the outcome measures.
Statistically significant improvements were found
in both walking tests for PEPR which is in keeping
with other literature and no natural recovery was
observed. However, conclusions were difficult to
draw due to the low sample in D-PEPR.
Conclusion
In summary, there is strong evidence that demon-
strates the benefits of PEPR.1 However, referral rate
and uptake rate are low for PEPR and the benefits are
only reaching a small number of those patients.4 In
relation to this study, we found recruitment and reten-
tion of patients problematic. This may be due to the
unstable nature of the condition following an exacer-
bation or due to patient reluctance to partake in a
structured programme soon after hospitalization.
Although our results suggested that those patients
who attended PR sooner after an AECOPD showed
better improvements than the delayed group, it is pro-
blematic to draw any firm conclusions due to the
significantly small sample number.
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